Toyota Faces Challenges Despite Hybrid Demand Boosting Earnings

Toyota Motor is expected to report another quarter of double-digit growth, driven by strong demand for hybrids, when it announces its earnings on Thursday. However, signs of slowing growth are emerging after a streak of record profits. Analysts will closely examine how much momentum the world’s top-selling automaker has lost from previous quarters, amid challenges…

Cryptocurrency Could Be Legalized By Russia For International Payments Because Of Western Sanctions

Russia is contemplating the legalization of cryptocurrency for international payments as the country faces sustained financial pressure from Western sanctions. The State Duma, the lower house of the Russian Parliament, will review a law on Tuesday that permits international payments via cryptocurrencies, according to Elvira Nabiullina, the governor of Russia’s central bank. “Today, the State…

OPEC+ Panel Expected to Maintain Production Cuts Despite Recent Oil Price Decline

An upcoming meeting of the OPEC+ panel is anticipated to maintain the current production cut agreement and delay any new adjustments, despite a recent sharp drop in oil prices, according to multiple sources within the producer group. The Organization of the Petroleum Exporting Countries and its allies, collectively known as OPEC+, are scheduled to hold…

Softbank-Backed Ola Electric, Funded By Softbank, Targets IPO To Raise $734 Million, Largest In India This Year

The largest domestic initial public offering (IPO) of the year is expected to raise $734 million, according to Indian e-scooter manufacturer Ola Electric. Foreign investors are interested in the sale, although the SoftBank-backed company was recently valued at a much reduced $4 billion. The IPO coincides with a boom in the Indian stock market, with…

Swiss Pharmaceutical Behemoth Roche Will Expedite Wegovy Competitor Medications Following Encouraging Testing Results

The behemoth of Swiss pharmaceuticals, Roche, said on Monday that it is accelerating the development of its Wegovy competitor weight-loss medications in light of encouraging early-stage trial results. The company’s two obesity medication candidates are moving forward in the clinical trial process and may hit the market in the coming years, offering a possible pill-based…

Food Delivery Costs Are Increasing, And The Impact Is Felt By Everybody

How much would it cost to have food delivered to your home from the restaurant of your choice? Due to the increasing popularity of delivery apps such as Grubhub, DoorDash, and Uber Eats in daily eating, third-party meal delivery is becoming the standard for American customers. Additionally, it presents a growingly complex equation including service…

EU Regulatory Body Rejects Lecanemab, An Alzheimer’s Medicine

A licence for an Alzheimer’s medication that reduces cognitive decline has been denied by the European Medicines Agency (EMA). According to the EMA, lecanemab’s advantages did not outweigh the possibility of major adverse effects, such as brain swelling and haemorrhage. A decision about the granting of a licence is still pending from the UK’s pharmaceuticals…